The present invention relates generally to the field of
genome editing, provides methods for producing
DNA recombinases that efficiently and specifically recombine genomic target sequences with
obligate DNA recombinase enzymes, and provides
DNA recombinases. More specifically, the present invention provides an engineered DNA
recombinase for efficient and specific
genome editing, comprising an
obligate complex of
recombinase, said complex comprising at least a first recombinase
enzyme and at least a second recombinase
enzyme, said first recombinase
enzyme and said second recombinase enzyme specifically recognizing a first half-site and a second half-site of an upstream
target site and / or a downstream
target site of
a DNA recombinase, said first recombinase enzyme and said second recombinase enzyme each comprising at least one
mutation in a catalytic site, said first recombinase enzyme and said second recombinase enzyme carrying said at least one
mutation in a catalytic site do not exhibit catalytic activity of
a DNA recombinase when expressed alone, and said catalytic activity as
a DNA recombinase is complemented in the
obligate complex of recombinase. The present invention further relates to
nucleic acid molecules encoding said engineered DNA recombinases and obligate complexes, and to the use of said engineered DNA recombinases and obligate complexes and
nucleic acid molecules in pharmaceutical compositions.